Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In Copenhagen
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including ChicagoThis summary needs review. Please check the official study record and contact the research team for details.
In BostonThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including El DoradoThis summary needs review. Please check the official study record and contact the research team for details.
In New YorkThis study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
In MaastrichtThis study was terminated in Sweden. It is testing Extended-release injectable suspension naltrexone as an adjunt pharmacotherapy for prevention of substance use in patients with SUD who are currently in treatment for ADHD.
In SwedenThis summary needs review. Please check the official study record and contact the research team for details.
In New YorkThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BirminghamThis summary needs review. Please check the official study record and contact the research team for details.
In New YorkThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including TarzanaThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BirminghamHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.